Veterinary Medicines Information website

VANGUARD 7 sospensione iniettabile per cani

Authorised
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Canine distemper virus, strain N-CDV, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
Download as PDF

Product identification

Medicine name:
VANGUARD 7 sospensione iniettabile per cani
Active substance:
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Canine distemper virus, strain N-CDV, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
Target species:
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine adenovirus 2, strain Manhattan, Live
    3.20
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    6.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain NL-35-D, Live
    7.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain N-CDV, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    463.00
    relative unit(s)
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
    420.00
    relative unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Italia S.r.l
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 23/03/2023
Download